ArticleOncotarget2015

PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors.

Annalisa Lonetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.